October 29, 2012
CDC and FDA are investigating a multistate outbreak of fungal meningitis and joint infections associated with steroid injections from the New England Compounding Center (NECC);
Unopened medication vials of preservative-free methylprednisolone acetate (80mg/ml)from NECC have been found to contain a fungus known as Exserohilum rostratum.
For up-to-date information on outbreak, visit the Centers for Disease Control's website:
The website also provides guidance to providers on testing, follow up, and treatment of patients who may have been exposed.
In addition to the injectable steroid,the FDA advises that other NECC injectable products administered to patients after May 21, 2012, including an injectable ophthalmic drug and a cardioplegic solution, may also pose a risk. More information about these products and additional safety information can be found on the FDA website:
NEW!! Download CDC Health Advisory - Nov 1, 2012
Download Physician Alert
Download NECC recall list
Learn more here